Ligand validation:1UXG

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 1UXG designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1UXG_NAD_A_1310	86%	7%	0.097	0.964	2.39	2.45	11	16	1	0	100%	1
1UXG_NAD_B_1310	84%	7%	0.099	0.961	2.42	2.49	13	17	1	0	100%	1
1UXH_NAD_A_1310	83%	6%	0.099	0.957	2.51	2.44	11	16	1	0	100%	1
1UXI_NAD_A_1310	81%	7%	0.107	0.959	2.37	2.44	12	15	3	0	100%	1
1UXJ_NAD_C_1310	78%	7%	0.089	0.931	2.45	2.47	12	16	2	0	100%	1
1UXK_NAD_A_1307	65%	6%	0.111	0.912	2.48	2.49	11	16	2	0	100%	1
1GUY_NAD_C_1307	62%	6%	0.148	0.939	2.41	2.53	12	16	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.